Unidirectional Transit of a Nonsymmetric Molecular Axle
FULL PAPER
Compound 12b was isolated as a white solid (1.3 g, 77%). M.p. 171.8–
173.88C; 1H NMR (300 MHz, CDCl3): d=9.29 (d, J=6.5 Hz, 2H), 8.74
(d, J=6.5 Hz, 2H), 8.18 (d, J=6.5 Hz, 2H), 7.94 (d, J=8 Hz, 2H), 7.73
(d, J=8 Hz, 2H), 7.57 (d, J=6 Hz, 2H), 7.51 (d, J=8 Hz, 2H), 7.45 (d,
J=8 Hz, 2H), 7.38 (d, J=8 Hz, 2H), 7.17 (d, J=16.5 Hz, 2H), 7.08 (d,
J=6 Hz, 2H), 7.04 (d, J=16.5 Hz, 2H), 4.77 (d, J=7 Hz, 2H), 4.20 (d,
J=7 Hz, 2H), 2.23 (s, 3H), 1.94 (d, J=7 Hz, 2H), 1.64 (d, J=7 Hz, 2H),
1.31 ppm (brs, 13H); 13C NMR (75 MHz, CD3OD): d=166.6, 154.1,
151.7, 145.9, 142.4, 141.3, 139.7, 134.3, 131.4, 130.2, 129.0, 126.8, 126.5,
126.2, 126.1, 121.9, 64.9, 62.1, 34.9, 31.8, 31.2, 28.7, 26.0, 25.9, 21.3 ppm;
MS (ESI): m/z (%): 519 (100) [MÀTsO]+.
(4 mL). After stirring at RT for 2 h, the resulting deep-red colored
hetero
submitted to NMR analysis with no further purification.
Compound P
1H NMR (300 MHz, C6D6): d=9.5 (brs, 6H), 8.44
ACHTUNGTRENgNUNG eneous solution was filtered off to remove the excess of axle and
A
:
(d, J=8 Hz, 2H), 8.27 (d, J=8 Hz, 4H), 8.2–7.9 (3br s, 10H), 7.70 and
7.7–7.5 (s and m overlapped, 9H), 7.42 (d, J=8 Hz, 6H), 7.2–6.8 (m, d,
J=8 Hz, m, 26H), 4.66 (d, J=14 Hz, 6H), 4.41 (brt, J=7 Hz, 2H), 4.1–
3.3 (s, brs, brs and m, 48H), 2.1–2.0 and 2.06 (brs and s overlapped, 8H),
1.80 and 1.69 (2s, 36H), 1.5–1.1 (2m, 22H), 1.1–0.9 ppm (brs, 6H).
Compound P
[1ꢀ3]up
:
1H NMR (300 MHz, C6D6): d=9.5 (brs, 6H), 8.44
(d, J=7.5 Hz, 2H), 8.26 (brd, J=6 Hz, 4H), 8.2–7.8 (3brs, 10H), 7.8
(brs, 2H), 7.69 (s, 6H), 7.6–7.5 (m, 12H), 7.2–7.1 (m, 12H), 7.03 (d, J=
8 Hz, 4H), 7.0–6.7 (m, 7H), 4.66 (d, J=15 Hz, 6H), 4.41 (brs, 2H), 4.1–
3.3 (s, brs, brs and m, 48H), 2.2 (brs, 6H), 2.0 (brs, 6H), 1.9–1.5 (2brs,
34H), 1.5, 1.36 and 1.20 (brs, s and brt, J=7 Hz, 38H), 1.1–0.9 ppm (brs,
6H).
General procedure for the synthesis of axles 2 and 3: 6-Hydroxyhexyl
tosACHTUNGTRENNUNGylate (10) (0.3 g, 1.1 mmol) and the appropriate salt 12a and 12b
(0.7 mmol) were dissolved in CH3CN (50 mL). The resulting reaction
mixture was heated to reflux for ten days and then cooled to room tem-
perature. The solvent was evaporated to dryness under reduced pressure
and the crude yellowish solid residue was triturated with hot ethyl ace-
tate (2ꢂ25 mL). After decantation of the ethyl acetate, the desired axles
2 and 3 were purified by recrystallization from CH3CN.
General procedure for synthesis of R
[1ꢀ4]up and R
ACHTUNGTRENNUNG
(0.04 mmol) was suspended in solution of compound
a
1
0.04 mmol) in dry toluene (10 mL). The resulting heterogeneous mixture
was stirred at RT until the solution turned to a deep-red color (2 h). Di-
phenylacetyl chloride (0.015 g, 0.06 mmol) and triethylamine (0.006 g,
0.06 mmol) were then added. After three days the solvent was completely
removed under reduced pressure. The red solid residue was dissolved in
CH2Cl2 (15 mL) and the solution extracted with an aqueous solution of
HCl (10% w/v, 2ꢂ15 mL). The separated organic phase was extracted
with an aqueous solution of NaOTs (2ꢂ15 mL) to regenerate the TsOÀ
ions. The separated organic phase was then dried with CaCl2 and evapo-
rated to dryness under reduced pressure.
Compound 2 was isolated as a white solid (0.45 g, 70%). M.p. 127.0–
128.28C; 1H NMR (300 MHz, CD3OD): d=9.21–9.17 (m, 4H), 8.60 (d,
J=6.5 Hz, 4H), 7.95 (d, J=8.5 Hz, 2H), 7.67 (d, J=8.5 Hz, 2H), 7.63 (d,
J=8.5 Hz, 2H), 7.56 (d, J=7.5 Hz, 2H), 7.39–7.27 (m, 5H), 7.19 (d, J=
8 Hz, 6H), 4.7–4.6 (m, 4H), 4.30 (t, J=6.5 Hz, 2H), 3.54 (t, J=6.5 Hz,
2H), 2.33 (s, 6H), 2.1 (brs, 4H), 1.8 (brs, 2H), 1.6–1.3 ppm (m, 10H);
13C NMR (100 MHz, CD3OD): d=172.9, 166.6, 149.7, 145.6, 142.3, 140.3,
138.9, 136.8, 131.3, 129.6, 128.7, 128.6, 128.4, 128.2, 128.0, 126.9, 126.6,
126.2, 125.6, 64.5, 61.8, 56.9, 30.9, 30.8, 27.9, 25.4, 25.2, 24.8, 21.1,
20.0 ppm; MS (ESI): m/z (%): 281 (50) [MÀ2TsO]2+
.
Compound R
ACHTUNGTRENNUNG
Compound 3 was isolated as a white solid (0.47 g, 70%). M.p. 131.3–
132.88C; 1H NMR (300 MHz, CD3OD): d=9.2 (brs, 4H), 8.6 (brs, 4H),
7.93 (d, J=8.3 Hz, 2H), 7.67 (d, J=8.3 Hz, 2H), 7.60 (d, J=8.3 Hz, 2H),
7.49 (d, J=8.3 Hz, 2H), 7.39 (d, J=8.3 Hz, 2H), 7.2–7.1 (m, 6H), 4.8–4.6
(m, 4H), 4.30 (t, J=6 Hz, 2H), 3.54 (t, J=6 Hz, 2H), 2.33 (s, 6H), 2.1
(brs, 4H), 1.8 (brs, 2H), 1.7–1.4 (m, 10H), 1.31 ppm (s, 9H); 13C NMR
(75 MHz, CD3OD): d=170.4, 155.2, 153.6, 149.5, 147.0, 146.3, 144.2,
137.9, 134.9, 133.41, 132.37, 130.7, 130.2, 130.0, 129.9, 129.4, 129.2, 68.3,
65.6, 65.1, 37.9, 35.7, 34.9, 34.8, 34.2, 31.9, 29.4, 29.3, 29.1, 28.8, 23.8 ppm;
MS (ESI): m/z (%): 986 (15) [M+Na]+, 791 (30) [MÀTsO]+, 310 (100)
(3ꢂ20 mL) to afford 0.06 g of RAHCTNUGTRENNNUG
122.88C; 1H NMR (300 MHz, C6D6): d=9.47 (s, 6H), 8.43 (d, J=8.1 Hz,
2H), 8.3 (brs, 4H), 8.2–7.9 (m, 10H), 7.8 (brs, 3H), 7.69 (s, 6H), 7.6–7.5
(m, 13H),7.45 (d, J=7.3 Hz, 2H), 7.3–7.1 (m, 16H), 7.1–6.9 (m, 5H), 6.8
(brs, 7H), 5.22 (s, 1H), 4.65 (d, J=14.5 Hz, 6H), 4.5–4.4 (m, 4H), 4.0
(brs, 15H), 3.7 (brs, 8H), 3.6–3.4 (m, 14H), 2.2 (brs, 2H), 2.06 (s, 6H)
1.9 (brs, 4H), 1.79 (s, 29H), 1.6 (brs, 2H), 1.40 (s, 9H), 1.4–1.1 (m, 11H),
0.9–0.8 ppm (m, 4H); 13C NMR (100 MHz, C6D6): d=172.1, 166.0, 153.5,
152.8, 148.1, 148.0, 144.4, 142.9, 141.2, 139.5, 139.0, 137.5, 137.1, 133.8,
132.1, 131.0, 130.0, 129.7, 129.3, 128.9, 128.8, 128.6, 128.4, 126.9, 126.5,
125.7, 124.8, 121.2, 118.1, 116.7, 72.4, 69.9, 66.3, 64.5, 61.0, 60.6, 57.3, 34.5,
31.5, 29.8, 29.2, 28.6, 28.3, 26.9, 25.7, 25.2, 20.8, 15.2 ppm; MS (ESI): m/z
[MÀ2TsO]2+
.
General procedure for the synthesis of dumbbells 4 and 5: The same pro-
cedure as employed for the synthesis of compounds 2 and 3 but by using
6-(tosyloxy)hexyl 2,2-diphenylacetate (13) (1.1 mmol) as alkylating agent.
(%): 1112 (100) [MÀ2TsO]2+
; elemental analysis calcd (%) for
C155H176O22S2N8 (2567.25): C 72.52, H 6.91, S 2.50, N 4.36; found: C
72.89, H 7.03, S 2.37, N 4.39.
Compound 4 was isolated as a white solid (0.57 g, 75%). M.p. 172.5–
173.58C; 1H NMR (300 MHz, [D6]DMSO): d=9.24 (d, J=7 Hz, 2H),
9.19 (d, J=7 Hz, 2H), 8.62 (d, J=6 Hz, 4H), 7.98 (d, J=8.5 Hz, 2H),
7.8–7.5 (m, J=8.5 Hz, 8H), 7.4–7.2 (m, 17H), 5.08 (s, 1H), 4.73 (t, J=
7.5 Hz, 2H), 4.63 (t, J=7.5 Hz, 2H), 4.32 (t, J=6.5 Hz, 2H), 4.14 (t, J=
6.5 Hz, 2H), 2.34 (s, 6H), 2.2–2.1 (m, 2H), 2.1–2.0 (m, 2H), 1.9–1.8 (m,
2H), 1.7–1.5 (m, 6H), 1.3 ppm (brs, 4H); 13C NMR (75 MHz,
[D6]DMSO): d=168.2, 151.5, 147.3, 144.2, 142.1, 140.7, 138.7, 132.9,
131.2, 130.4, 130.2, 130.0, 129.9, 129.6, 128.6, 128.5, 128.2, 127.8, 127.2,
66.1, 63.5, 64.4, 58.5, 32.6, 32.5, 29.8, 29.5, 27.1, 26.9, 26.8, 26.5, 21.6 ppm;
MS (ESI): m/z (%) 379.1 (100) [MÀ2TsO]2+, 929 (15) [MÀTsO]+.
Compound R
ACHTUNGTRENNUNG
(3ꢂ20 mL) to afford 0.06 g of RAHCTNUGTRENNNUG
1H NMR (300 MHz, C6D6): d=9.5 (brs, 6H), 8.43 (d, J=8 Hz, 2H), 8.3
(brs, 4H), 8.1–7.9 (m, 10H), 7.8 (brs, 3H), 7.69 (s, 6H), 7.6–7.4 (m,
13H), 7.3–7.1 (m, 13H), 7.04 (brs, 5H), 6.9 (brs, 2H), 6,8 (brs, 5H), 5.22
(s, 1H), 4.65 (d, J=14.5 Hz, 6H), 4.5–4.4 (m, 4H), 4.1–3.9 (brs, 15H),
3.8–3.6 (brs, 8H), 3.6–3.4 (m, 14H), 2.2 (brs, 2H), 2.1 (s, 6H) 1.9 (brs,
4H), 1.79 (s, 29H), 1.6 (brs, 2H), 1.40 (s, 9H), 1.4–1.1 (m, 11H), 0.9 ppm
(brs, 4H); 13C NMR (100 MHz, C6D6): d=172.1, 166.0, 153.5, 152.8,
151.0, 148.1, 148.0, 144.3, 143.0, 142.0, 141.0, 139.6, 139.3, 139.0, 137.4,
134.4, 133.8, 132.1, 131.0, 130.0, 129.5, 129.2, 129.1, 129.0, 128.9, 128.7,
128.4, 127.0, 126.9, 126.8, 126.5, 125.7, 124.8, 121.2, 119.6, 119.1, 118.1,
116.7, 72.4, 69.9, 66.3, 64.9, 64.5, 61.0, 60.6, 59.7, 57.3, 57.1, 34.5, 34.3,
34.1, 31.5, 31.0, 29.8, 29.3, 29.2, 28.6, 28.2, 27.7, 26.8, 26.0, 25.2, 20.8,
15.2 ppm; MS (ES): m/z (%): 1140 (100) [MÀ2TsOÀ]2+; elemental analy-
sis calcd (%) for C159H188O22S2N8 (2623.35): C 72.79, H 7.07, S 2.44, N
4.27; found: C 73.51, H 7.30, S 1.69, N 4.27.
Compound 5 was isolated as a white solid (0.56 g, 70%). M.p. 176.5–
177.58C; 1H NMR (300 MHz, CD3OD): d =9.22 (d, J=8 Hz, 2H), 9.17
(d, J=8 Hz, 2H), 8.60 (d, J=6.5 Hz, 2H), 7.95 (d, J=8 Hz, 2H), 7.67 (d,
J=8 Hz, 4H), 7.62 (d, J=8 Hz, 2H), 7.51 (d, J=8 Hz, 2H), 7.41 (d, J=
8 Hz, 2H), 7.3–7.1 (m, 16H), 5.05 (s, 1H), 4.73 (t, J=7.5 Hz, 2H), 4.62 (t,
J=7.5 Hz, 2H), 4.31 (t, J=6.5 Hz, 2H), 4.13 (t, J=6.5 Hz, 2H), 2.33 (s,
6H), 2.12–2.08 (m, 2H), 2.02–1.96 (m, 2H), 1.81 (t, J=7 Hz, 2H), 1.7–1.5
(m, 6H), 1.32 ppm (s, 9H); 13C NMR (75 MHz, CD3OD): d=171.9,
165.9, 147.3, 142.0, 132.7, 131.2, 130.1, 129.9, 129.8, 128.0, 127.7, 127.2,
127.0, 66.1, 63.4, 58.5, 32.6, 32.5, 31.9, 29.9, 29.5, 27.1, 26.9, 26.8, 26.5,
Synthesis of R
[1ꢀ4]down: To a solution of wheel 1 (0.013 g, 0.009 mmol) in
C6D6 (0.6 mL) placed in a 5 mm NMR tube axle 4 (0.01 g, 0.009 mmol)
was added. The resulting heterogeneous mixture was heated to 708C for
12 h until the solution turned homogeneous and deep-red colored and
21.6 ppm; MS (ESI): m/z (%) 407.4 (100) [MÀ2TsO]2+
.
1
General procedure for synthesis of P
[1ꢀ2]up and P
[1ꢀ3]up: In a round-
analyzed by H and 13C NMR spectroscopy as well as mass spectrometry.
bottomed flask, the proper amount of the axle (2 or 3) (0.05 mmol) was
suspended in a solution of compound 1 (0.06 g, 0.04 mmol) in C6D6
1H NMR (300 MHz, C6D6): d=9.5 (brs, 6H), 8.4 (d, J=8 Hz, 2H), 8.28
(d, J=7 Hz, 4H), 8.2 (brs, 2H), 8.1 (brs, 6H), 7.95 (d, J=6.5 Hz, 2H),
Chem. Eur. J. 2012, 18, 16203 – 16213
ꢁ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
16211